Shadowfax Technologies Reports Zero Deviation in IPO Proceeds Utilization for Q2FY27
Shadowfax Technologies Ltd · Others (Uncategorized) · 29 Oct 2026, 10:11 pm
Shadowfax Technologies Reports Zero Deviation in IPO Proceeds Utilization for Q2FY27 CARE Ratings confirmed Shadowfax Technologies experienced zero object deviations in utilizing proceeds from its ₹1,000 crore fresh IPO issue for the quarter ended 30th Sep'26. The company utilized ₹101.67 crore during Q2FY27, bringing cumulative deployment to ₹289.42 crore. Key spending included ₹76.61 crore on network infrastructure capex (reaching ₹198.18 crore cumulatively), ₹15.10 crore on facility lease rentals, and ₹7.76 crore on branding. Unutilized proceeds totaling ₹710.58 crore remain predominantly invested in bank fixed deposits earning 6.50%–7.25% yields.
Original exchange filing (PDF)
More announcements from Shadowfax Technologies Ltd
- Increase in ESOP Pool and Grant of Employee Stock Options under Shadoowfax Technologies Limited-Employee Stock Option Plan · 17 Nov 2026
- Shadowfax Technologies Limited has informed the Exchange about Schedule of Investors Conference/Analyst Meet · 12 Nov 2026
- Allotment of 17,61,552 Equity Shares of Rs. 10/- each to the eligible employees/ESOP holders · 06 Nov 2026
- Shadowfax Technologies Limited has informed the exchange about Transcript of Earnings Conference Call for Q2 FY 27 held on October 29, 2026 · 03 Nov 2026
- Intimation w.r.t Audio recording of the Earnings Conference Call held on October 29, 2026 · 30 Oct 2026
- Earnings Presentation on the Unaudited (Stanalone & Consolidated) financial results for ther quarter and half year ended September 30, 2026 · 29 Oct 2026
- Press Release on the Financial Results for the Quarter and Half Year ended September 30, 2026 · 29 Oct 2026
- Results for the Quarter and half year ended September 30, 2026 · 29 Oct 2026
